Devonian Health Group Inc.
GSD.V
TSX
| 10/31/2024 | 07/31/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -35.80% | 76.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -35.80% | 76.72% | |||
| Cost of Revenue | -27.00% | 45.67% | |||
| Gross Profit | -50.35% | 172.79% | |||
| SG&A Expenses | -19.77% | 53.51% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | 6.42% | -0.91% | |||
| Total Operating Expenses | -21.91% | 45.26% | |||
| Operating Income | -126.87% | 521.16% | |||
| Income Before Tax | -133.56% | 386.53% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -133.56% | 386.53% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -133.56% | 386.53% | |||
| EBIT | -126.87% | 521.16% | |||
| EBITDA | -115.43% | 949.85% | |||
| EPS Basic | -133.96% | 378.95% | |||
| Normalized Basic EPS | -133.33% | 375.00% | |||
| EPS Diluted | -133.96% | 378.95% | |||
| Normalized Diluted EPS | -133.33% | 375.00% | |||
| Average Basic Shares Outstanding | -0.01% | 1.02% | |||
| Average Diluted Shares Outstanding | -0.01% | 1.02% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
